Eprobemide information

Eprobemide
Clinical data
Trade names	Befol (RU)
Other names	Befol
Routes of; administration	Oral
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 4-Chloro-N-[3-(4-morpholinyl)propyl]benzamide;
CAS Number	87940-60-1;
PubChem CID	65659;
ChemSpider	59094;
UNII	URX5F7RDER;
ChEMBL	ChEMBL2104298;
CompTox Dashboard (EPA)	DTXSID3046409 ;
Chemical and physical data
Formula	C14H19ClN2O2
Molar mass	282.77 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1COCCN1CCCNC(=O)C2=CC=C(C=C2)Cl;
	InChI InChI=1S/C14H19ClN2O2/c15-13-4-2-12(3-5-13)14(18)16-6-1-7-17-8-10-19-11-9-17/h2-5H,1,6-11H2,(H,16,18); Key:YYFGRAGNYHYWEZ-UHFFFAOYSA-N;

Eprobemide (INN) is a pharmaceutical drug that was used as an antidepressant in Russia (under the brand name Бефол/Befol).^[1] It is a non-competitive reversible inhibitor of monoamine oxidase A^[2]^[3] that exhibits selective action on serotonin deamination.^[4] Eprobemide differs from moclobemide only in the linker that connects the morpholine fragment with the chlorobenzamide — moclobemide has two carbon atoms while eprobemide has three. Its registration was cancelled on December 30, 2003.^[5]

^ Ganellin CR, Triggle DJ (1996). Dictionary of Pharmacological Agents. Vol. 3. p. 811. ISBN 978-0412466304.
^ Gol'dina OA, Moskvitina TA, Gankina EM, Kirkel' AZ, Kamyshanskaia NS, Lopatina KI, et al. (March 1991). "[The action of befol and its derivatives on monoamine oxidase of different origins]". Biulleten' Eksperimental'noi Biologii I Meditsiny. 111 (3): 279–80. PMID 2054504.
^ Donskaya NS, Antonkina OA, Glukhan EN, Smirnov SK (2004-07-01). "Antidepressant Befol Synthesized Via Interaction of 4-Chloro-N-(3-chloropropyl)benzamide with Morpholine". Pharmaceutical Chemistry Journal. 0091-150X. 38 (7): 381–384. doi:10.1023/B:PHAC.0000048439.38383.5f. S2CID 29121452.
^ "Eprobemide". ChemIDplus.
^ "Befol". 4DOKTOR.RU Drug Information Handbook (in Russian). Retrieved 4 February 2014.

[1] Ganellin CR, Triggle DJ (1996). Dictionary of Pharmacological Agents. Vol. 3. p. 811. ISBN 978-0412466304.

[2] Gol'dina OA, Moskvitina TA, Gankina EM, Kirkel' AZ, Kamyshanskaia NS, Lopatina KI, et al. (March 1991). "[The action of befol and its derivatives on monoamine oxidase of different origins]". Biulleten' Eksperimental'noi Biologii I Meditsiny. 111 (3): 279–80. PMID 2054504.

[3] Donskaya NS, Antonkina OA, Glukhan EN, Smirnov SK (2004-07-01). "Antidepressant Befol Synthesized Via Interaction of 4-Chloro-N-(3-chloropropyl)benzamide with Morpholine". Pharmaceutical Chemistry Journal. 0091-150X. 38 (7): 381–384. doi:10.1023/B:PHAC.0000048439.38383.5f. S2CID 29121452.

[4] "Eprobemide". ChemIDplus.

[5] "Befol". 4DOKTOR.RU Drug Information Handbook (in Russian). Retrieved 4 February 2014.

Eprobemide information

and 25 Related for: Eprobemide information

Eprobemide

Ketamine

List of antidepressants

Antidepressant

Sertraline

Trazodone

Diphenhydramine

Psychiatry

Venlafaxine

Tobacco

Bupropion

Hypericum perforatum

Buspirone

Fluoxetine

Mirtazapine

Buprenorphine

Monoamine oxidase inhibitor

Amitriptyline

Atypical antidepressant

Tricyclic antidepressant

Duloxetine

Vortioxetine

Citalopram

Selective serotonin reuptake inhibitor

Clomipramine